β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 18, Issue 6, Pages 892-901
Publisher
Springer Nature
Online
2012-05-21
DOI
10.1038/nm.2772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
- (2011) Ana R. Gomes et al. CELL CYCLE
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2
- (2011) Rodrigo Dienstmann et al. Recent Patents on Anti-Cancer Drug Discovery
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity
- (2010) A Barbáchano et al. ONCOGENE
- Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway
- (2010) Christophe Fuerer et al. PLoS One
- Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer
- (2010) Jie Chen et al. PLoS One
- FADD: a regulator of life and death
- (2010) Léa Tourneur et al. TRENDS IN IMMUNOLOGY
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
- (2009) P. Storz et al. MOLECULAR AND CELLULAR BIOLOGY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Bone Marrow Stem Cells Expressing Keratinocyte Growth Factor via an Inducible Lentivirus Protects against Bleomycin-Induced Pulmonary Fibrosis
- (2009) Susana Aguilar et al. PLoS One
- Discovery of Drug-Resistant and Drug-Sensitizing Mutations in the Oncogenic PI3K Isoform p110α
- (2008) Eli R. Zunder et al. CANCER CELL
- Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity
- (2008) Diana Hoogeboom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wnt Signaling Inhibits Forkhead Box O3a-induced Transcription and Apoptosis through Up-regulation of Serum- and Glucocorticoid-inducible Kinase 1
- (2008) Manuel Dehner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The FoxO code
- (2008) D R Calnan et al. ONCOGENE
- The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis
- (2008) Héctor G. Pálmer et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started